-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...

-The Hindu India spends less of its GDP on health than some of the world’s poorest countries’ Every government hospital serves an estimated 61,000 people in India, with one bed for every 1833 people, new official data shows. In undivided Andhra Pradesh, every government hospital serves over 3 lakh patients while in Bihar, there is only one bed for every 8800 people. Union Minister for Health J.P. Nadda released the National Health Profile...

-The Times of India NEW DELHI: In an attempt to increase accessibility of information and treatment of HIV, National Aids Control Organization (NACO) has rolled out a mobile app for AIDS awareness and prevention. The app, first of its kind in India, is based on various international models. The app would provide all kinds of information on AIDS, which is not easily available otherwise. For instance, it will provide information of HIV...

-The Indian Express The steady state efficiency of healthcare needs to be raised so that crises like this one can be avoided. In any free society where terrible wrongs exist, some are guilty; all are responsible.” While these words of Rabbi Abraham Joshua Heschel ring true for many social and political ills that appall us, they are also a timely reminder of our collective responsibility to correct the pathetic state of...

-The Times of India MUMBAI: Certain Medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced Medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...